ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years
Shi Feng
Matched on ORCID iD 0009-0009-5468-9791; OpenAlex author ID A5112158246. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- Cancer Cell-Derived Exosomal miR-519a/522-5p Promotes Pancreatic Cancer Progression by Enhancing Warburg Effect. Co-author DOI 10.1245/s10434-025-17540-1↗
- Integrated chromosomal instability and tumor microbiome redefined prognosis-related subtypes of pancreatic cancer. Co-author DOI 10.1016/j.hbpd.2024.03.002↗
- Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages. First author DOI 10.1111/jcmm.16281↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qi Ling · 3 shared papers, 2021–2025 · strength 0.63
- Paper Cancer Cell-Derived Exosomal miR-519a/522-5p Promotes Pancreatic Cancer Progression by Enhancing Warburg Effect. DOI 10.1245/s10434-025-17540-1↗
- Paper Integrated chromosomal instability and tumor microbiome redefined prognosis-related subtypes of pancreatic cancer. DOI 10.1016/j.hbpd.2024.03.002↗
- Paper Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages. DOI 10.1111/jcmm.16281↗
- Ruihan Chen · 2 shared papers, 2021–2024 · strength 0.35
- Xueyou Zhang · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.